Prevalence of Metabolic Syndrome Among the End-Stage Renal Disease Patients on Hemodialysis

BACKGROUND: Patients with metabolic syndrome (MetS) have a 2.6-fold greater risk of incident chronic kidney disease (CKD). The primary goal of this study was to assess the prevalence of MetS in patients with end-stage renal disease (ESRD) who are on hemodialysis (HD) and the impact of MetS presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Alswat, Khaled A., Althobaiti, Awwadh, Alsaadi, Khulod, Alkhaldi, Amaal Saeed, Alharthi, Maryam Mutlaq, Abuharba, Walaa Abduraheem, Alzaidi, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505305/
https://www.ncbi.nlm.nih.gov/pubmed/28725317
http://dx.doi.org/10.14740/jocmr3064w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505305/
https://www.ncbi.nlm.nih.gov/pubmed/28725317
http://dx.doi.org/10.14740/jocmr3064w

Ejemplares similares